Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Homology Medicines Inc (FIXX)

Homology Medicines Inc (FIXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,338
  • Shares Outstanding, K 58,134
  • Annual Sales, $ 1,160 K
  • Annual Income, $ -112,960 K
  • 60-Month Beta -0.10
  • Price/Sales 46.65
  • Price/Cash Flow N/A
  • Price/Book 0.74
Trade FIXX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.28
  • Most Recent Earnings $-0.24 on 03/12/24
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +199,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8340 +12.07%
on 02/26/24
0.9725 -3.89%
on 03/25/24
+0.0726 (+8.42%)
since 02/23/24
3-Month
0.5611 +66.58%
on 01/03/24
0.9725 -3.89%
on 03/25/24
+0.3637 (+63.70%)
since 12/22/23
52-Week
0.4580 +104.08%
on 11/16/23
1.4800 -36.84%
on 08/01/23
+0.0247 (+2.71%)
since 03/24/23

Most Recent Stories

More News
Homology Medicines: Q3 Earnings Snapshot

Homology Medicines: Q3 Earnings Snapshot

FIXX : 0.9347 (+0.77%)
Homology Medicines: Q2 Earnings Snapshot

Homology Medicines: Q2 Earnings Snapshot

FIXX : 0.9347 (+0.77%)
Homology Medicines: Q1 Earnings Snapshot

Homology Medicines: Q1 Earnings Snapshot

FIXX : 0.9347 (+0.77%)
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -35.90% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GBIO : 3.26 (+16.01%)
FIXX : 0.9347 (+0.77%)
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of 37.78% and 7.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AMPH : 40.91 (+1.84%)
FIXX : 0.9347 (+0.77%)
BridgeBio Pharma (BBIO) Moves 9.7% Higher: Will This Strength Last?

BridgeBio Pharma (BBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength...

BBIO : 25.46 (+1.56%)
FIXX : 0.9347 (+0.77%)
Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates

Homology Medicines (FIXX) delivered earnings and revenue surprises of -17.65% and 23.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FIXX : 0.9347 (+0.77%)
SLGL : 0.9252 (-1.05%)
Homology Medicines: Q4 Earnings Snapshot

Homology Medicines: Q4 Earnings Snapshot

FIXX : 0.9347 (+0.77%)
Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -41.10% and 8.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 29.95 (+0.81%)
FIXX : 0.9347 (+0.77%)
BridgeBio Pharma (BBIO) Reports Q4 Loss, Lags Revenue Estimates

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -1.16% and 84.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BBIO : 25.46 (+1.56%)
FIXX : 0.9347 (+0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.

See More

Key Turning Points

3rd Resistance Point 1.0440
2nd Resistance Point 1.0082
1st Resistance Point 0.9715
Last Price 0.9347
1st Support Level 0.8990
2nd Support Level 0.8632
3rd Support Level 0.8265

See More

52-Week High 1.4800
Fibonacci 61.8% 1.0896
Fibonacci 50% 0.9690
Last Price 0.9347
Fibonacci 38.2% 0.8484
52-Week Low 0.4580

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar